Announcements Trials

Browse Landscape

Phase

Phase 2 36 Phase 3 30 Phase 1/2 7 Phase 1 3 Phase NA 2 Phase 4 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 28 INDUSTRY 20 OTHER_GOV 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 1 Ovarian Cysts 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Long Qt Syndrome 3 1 Localized Advanced Rectal Adenocarcinoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Infertility 1 Hodgkin Disease 1 Endometriosis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × NETWORK × Multiple Myeloma × Clear all

NCT05944783 2025-02-12

BE-Dasatinib

Centro de Atencion e Investigacion Medica

Phase 4 Not yet recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡